Health News
2006-10-21
Single anti-HIV
pill approved by the U.S.
Bristol-Myers
Squibb Co. said on Friday that U.S. regulators approved a
single-capsule form of its Reyataz HIV drug to be taken as
Bristol-Myers
Squibb Co. said on Friday that U.S. regulators approved a
single-capsule form of its Reyataz HIV drug to be taken as
part of combination drug therapy. Taken once a day,
the 300-milligram Reyataz can replace two
150-milligram capsules of the drug and will be available
within a week, the company said. (Reuters)
Click here to follow The Advocate on Twitter.
Page 1 of 1